Deep Vein Thrombosis
📧 Sign up to get email alerts when something new happens for Deep Vein Thrombosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Primary Care-Hospital Embedding: a Prospective, Multicentric, Observational Study
An observational, prospective multicenter study examining primary care–hospital embedding is active but not recruiting. It includes conditio…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study
Results from a UK matched-cohort study examine the risk of venous thromboembolism among people with systemic inflammatory disorders. The tri…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: IVUS-Guided Treatment for Percutaneous Vascular Interventions
A Philips-sponsored clinical trial evaluating IVUS-guided treatment for percutaneous vascular interventions is currently suspended.
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis [NA]
Clinical trial update evaluating tinzaparin's effect on inflammatory biomarkers during the acute phase of deep vein thrombosis; the study is…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: A Multi-center Cohort Study for Conventional Ultrasound Image Set Collection to Create a Data Set for Research Purposes.
A multi-center cohort study aims to collect conventional ultrasound image sets to create a dataset for research purposes, enrolling particip…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-05-15FDA Approved: RIVAROXABAN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for generic rivaroxaban, a direct oral anticoagulant.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE) [Phase 4]
Phase 4 trial update for the DANNOAC-VTE study evaluating non-vitamin K antagonist oral anticoagulants in venous thromboembolism (DVT and PE…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Improving Emergency Department Testing for Deep Vein Thrombosis
A clinical trial evaluating improved emergency department testing for deep vein thrombosis has completed.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Rheolytic Thrombectomy For Acute Deep Vein Thrombosis Of Whole Lower Limb [NA]
A clinical trial is recruiting to evaluate rheolytic thrombectomy for acute deep vein thrombosis of the whole lower limb, sponsored by RenJi…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Preservation of Venous Valvular Function After PMT for Acute DVT [NA]
Clinical trial evaluating preservation of venous valvular function after pharmacomechanical thrombectomy for acute deep vein thrombosis; stu…
-
FDA approval · 2025-05-14FDA Approved: RIVAROXABAN — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved an original application for rivaroxaban (generic) from XLCare Pharmaceuticals, Inc.
-
FDA approval · 2025-05-14FDA Approved: RIVAROXABAN — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original ANDA for rivaroxaban, making a generic rivaroxaban available in the U.S. for approved indic…
-
FDA approval · 2025-05-14FDA Approved: RIVAROXABAN — Original Application (Dr.Reddy's Laboratories, Inc.)
FDA approved Dr. Reddy's Laboratories' generic rivaroxaban for marketing (ANDA 208534), expanding access to the direct oral anticoagulant. T…
-
FDA approval · 2025-05-14FDA Approved: RIVAROXABAN — Original Application (Macleods Pharmaceuticals Limited)
The FDA approves Macleods Pharmaceuticals Limited's original (ANDA) application for rivaroxaban, a generic version of the anticoagulant.
-
FDA approval · 2025-05-14FDA Approved: RIVAROXABAN — Original Application (Changzhou Pharmaceutical Factory)
FDA approved the original application for rivaroxaban from Changzhou Pharmaceutical Factory under ANDA216995.
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Ongoing Registry of Treatment of Venous Thromboembolism
This document reports an ongoing registry study on the treatment of venous thromboembolism. It is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
This completed clinical trial (NCT05053100) investigates the risk of blood clots and bleeding in patients with hematologic cancers.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy Systems
This clinical trial update indicates a recruiting study evaluating mechanical thrombectomy systems for acute and subacute iliofemoral and ca…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: To Compare and Evaluate the Oral Bioavailability of Edoxaban 60 mg Film Coated Tablet With That of Lixiana® 60 mg Filmtabletten (Film Coated Tablet) (Edoxaban) in Healthy, Adult, Human Subjects Under Fasting Conditions [NA]
A completed pharmacokinetic trial comparing the oral bioavailability of a 60 mg Edoxaban film-coated tablet with Daiichi Sankyo's Lixiana 60…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease [Phase 3]
Phase 3 clinical trial comparing immunosuppressive therapy alone versus with oral anticoagulation for venous thrombotic involvement in Behçe…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Cardiovascular Complications and COVID-19 (CovCardioVasc-Study)
CovCardioVasc-Study, a trial investigating cardiovascular complications in COVID-19, has completed.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Registry of Patients Prescribed Anticoagulation
Mayo Clinic sponsors a clinical trial (NCT03504007) evaluating anticoagulation in patients with acute deep vein thrombosis or acute pulmonar…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Inflow Improve for Deep Vein ThrombOsis with Ultrasound AcceLerated ThrombOlysis and Venoplasty
An ongoing clinical trial is evaluating ultrasound-accelerated thrombolysis with venoplasty to improve inflow in patients with post-thrombot…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Six Years of Follow-up After Idiopathic Venous Throbmoembolism
The document reports six years of follow-up data from a study of idiopathic venous thromboembolism, including pulmonary embolism and proxima…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets [Phase 3]
Phase 3 clinical trial evaluating the best antithrombotic therapy for acute venous thromboembolism in patients already taking antiplatelets;…